Literature DB >> 31813090

D-dimer testing to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: follow the rules!

Alessia Abenante1, Francesca Zuretti1, Cristina Dedionigi1, Flavio Tangianu1, Francesco Dentali2.   

Abstract

Entities:  

Year:  2019        PMID： 31813090     DOI： 10.1007/s11739-019-02249-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  15 in total

1.  Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.

Authors:  Gualtiero Palareti; Cristina Legnani; Benilde Cosmi; Giuliana Guazzaloca; Claudia Pancani; Sergio Coccheri
Journal:  Thromb Haemost       Date:  2002-01       Impact factor: 5.249

2.  D-dimer testing to determine the duration of anticoagulation therapy.

Authors:  Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Carlotta Brusi; Alfonso Iorio; Vittorio Pengo; Angelo Ghirarduzzi; Corrado Pattacini; Sophie Testa; Anthonie W A Lensing; Armando Tripodi
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

3.  Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

Authors:  G Agnelli; P Prandoni; M G Santamaria; P Bagatella; A Iorio; M Bazzan; M Moia; G Guazzaloca; A Bertoldi; C Tomasi; G Scannapieco; W Ageno
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban.

Authors:  Davide Imberti; Cecilia Becattini; Enrico Bernardi; Giuseppe Camporese; Claudio Cuccia; Francesco Dentali; Damiano Paretti
Journal:  Intern Emerg Med       Date:  2018-03-08       Impact factor: 3.397

5.  A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Authors:  C Kearon; M Gent; J Hirsh; J Weitz; M J Kovacs; D R Anderson; A G Turpie; D Green; J S Ginsberg; P Wells; B MacKinnon; J A Julian
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

6.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

7.  D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.

Authors:  Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Emilia Antonucci; Valeria De Micheli; Angelo Ghirarduzzi; Daniela Poli; Sophie Testa; Alberto Tosetto; Vittorio Pengo; Paolo Prandoni
Journal:  Blood       Date:  2014-05-30       Impact factor: 22.113

8.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Authors:  Marc A Rodger; Susan R Kahn; Philip S Wells; David A Anderson; Isabelle Chagnon; Grégoire Le Gal; Susan Solymoss; Mark Crowther; Arnaud Perrier; Richard White; Linda Vickars; Tim Ramsay; Marisol T Betancourt; Michael J Kovacs
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

9.  External validation of the DASH prediction rule: a retrospective cohort study.

Authors:  A Tosetto; S Testa; I Martinelli; D Poli; B Cosmi; C Lodigiani; W Ageno; V De Stefano; A Falanga; I Nichele; O Paoletti; P Bucciarelli; E Antonucci; C Legnani; E Banfi; F Dentali; F Bartolomei; L Barcella; G Palareti
Journal:  J Thromb Haemost       Date:  2017-08-23       Impact factor: 5.824

Review 10.  Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Authors:  James Douketis; Alberto Tosetto; Maura Marcucci; Trevor Baglin; Benilde Cosmi; Mary Cushman; Paul Kyrle; Daniela Poli; R Campbell Tait; Alfonso Iorio
Journal:  BMJ       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.